Literature DB >> 27507661

Association between rheumatoid arthritis and systemic mastocytosis: a case report and literature review.

Ichraq Latar1, Meriem Koufany1, Julie Hablot1, Damien Loeuille2, Patrick Netter1, Jean-Yves Jouzeau1, Isabelle Chary-Valckenaere2, David Moulin3,4.   

Abstract

Classically, mast cells (MC) are considered as important actors of the innate immune response playing a pivotal role in IgE-mediated allergic and antiparasite responses. In the last two decades, many experimental evidences demonstrated that these hematopoietic-derived cells present in both connective and mucosal tissues are also key modulators of the adaptive immune response and could contribute to autoimmune disease notably in rheumatoid arthritis (RA). Recently, Bader-Meunier et al. reported a series of 31 patients suffering from inflammatory joint diseases associated with mastocytosis, suggesting that mastocytosis was associated with a higher prevalence in spondyloarthritis. We discuss here the possible link between chronic inflammatory arthritis and mastocytosis through the report of a clinical case describing a patient developing RA after a long history of mastocytosis. Of great interest, antihistamine treatment alone was sufficient to treat RA in this patient.

Entities:  

Keywords:  Mast cells; Mastocytosis; Osteoporosis; Rheumatoid arthritis

Mesh:

Substances:

Year:  2016        PMID: 27507661     DOI: 10.1007/s10067-016-3368-9

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  37 in total

1.  Osteoporosis and bone marrow mastocytosis: dissociation of skeletal responses and mast cell activity during long-term bisphosphonate therapy.

Authors:  Caroline Brumsen; Neveen A T Hamdy; Socrates E Papapoulos
Journal:  J Bone Miner Res       Date:  2002-04       Impact factor: 6.741

2.  2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

Authors:  Daniel Aletaha; Tuhina Neogi; Alan J Silman; Julia Funovits; David T Felson; Clifton O Bingham; Neal S Birnbaum; Gerd R Burmester; Vivian P Bykerk; Marc D Cohen; Bernard Combe; Karen H Costenbader; Maxime Dougados; Paul Emery; Gianfranco Ferraccioli; Johanna M W Hazes; Kathryn Hobbs; Tom W J Huizinga; Arthur Kavanaugh; Jonathan Kay; Tore K Kvien; Timothy Laing; Philip Mease; Henri A Ménard; Larry W Moreland; Raymond L Naden; Theodore Pincus; Josef S Smolen; Ewa Stanislawska-Biernat; Deborah Symmons; Paul P Tak; Katherine S Upchurch; Jirí Vencovsky; Frederick Wolfe; Gillian Hawker
Journal:  Ann Rheum Dis       Date:  2010-09       Impact factor: 19.103

Review 3.  Mast cells: ontogeny, homing, and recruitment of a unique innate effector cell.

Authors:  Michael F Gurish; Joshua A Boyce
Journal:  J Allergy Clin Immunol       Date:  2006-06       Impact factor: 10.793

4.  Systemic mastocytosis: a rare cause of osteoporosis and its response to bisphosphonate treatment.

Authors:  A Y N Lim; A J K Ostor; S Love; A J Crisp
Journal:  Ann Rheum Dis       Date:  2005-06       Impact factor: 19.103

5.  Mast cell-restricted, tetramer-forming tryptases induce aggrecanolysis in articular cartilage by activating matrix metalloproteinase-3 and -13 zymogens.

Authors:  Natalia J Magarinos; Katherine J Bryant; Amanda J Fosang; Roberto Adachi; Richard L Stevens; H Patrick McNeil
Journal:  J Immunol       Date:  2013-06-24       Impact factor: 5.422

6.  Mast cell activation in arthritis: detection of alpha- and beta-tryptase, histamine and eosinophil cationic protein in synovial fluid.

Authors:  M G Buckley; C Walters; W M Wong; M I Cawley; S Ren; L B Schwartz; A F Walls
Journal:  Clin Sci (Lond)       Date:  1997-10       Impact factor: 6.124

7.  Mast cell responses in rheumatoid synovium. Association of the MCTC subset with matrix turnover and clinical progression.

Authors:  I Gotis-Graham; H P McNeil
Journal:  Arthritis Rheum       Date:  1997-03

Review 8.  Mast cells in the pathogenesis of rheumatic diseases and as potential targets for anti-rheumatic therapy.

Authors:  Kari K Eklund
Journal:  Immunol Rev       Date:  2007-06       Impact factor: 12.988

Review 9.  Advances in mast cell biology: new understanding of heterogeneity and function.

Authors:  T C Moon; C D St Laurent; K E Morris; C Marcet; T Yoshimura; Y Sekar; A D Befus
Journal:  Mucosal Immunol       Date:  2009-12-30       Impact factor: 7.313

Review 10.  Mast cell-orchestrated immunity to pathogens.

Authors:  Soman N Abraham; Ashley L St John
Journal:  Nat Rev Immunol       Date:  2010-06       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.